---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-21-144456"
form_type: "8-K"
ticker: "NWBO"
cik: "0001072379"
company_name: "NORTHWEST BIOTHERAPEUTICS INC"
filed_at: "2021-11-29T23:59:59+00:00"
generated_at: "2026-06-28T05:03:12.957342+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# NWBO enters $15M loan with Streeterville; conversion right tied to Phase III data

## Summary
- Net proceeds of $15M from Streeterville Capital, LLC; 22-month maturity, 8% interest, 10% OID.
- No payments first 8 months, then 14 equal monthly principal installments at 110% pro rata plus interest.
- Lender gets springing right upon top-line data from DCVax-L Phase III to convert balance into shares at 12% discount to next private placement.
- Funds will be used for ongoing business operations.

## SEC filing metadata
- accession: 0001104659-21-144456
- form_type: 8-K
- ticker: NWBO
- cik: 0001072379
- company_name: NORTHWEST BIOTHERAPEUTICS INC
- filed_at: 2021-11-29T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 2.03
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1072379/000110465921144456/0001104659-21-144456-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1072379/000110465921144456/tm2134065d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-21-144456
- JSON: https://secwatch.observer/filing/0001104659-21-144456.json
- Plain text: https://secwatch.observer/filing/0001104659-21-144456.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.